This FAQ is taken from Flow matters COVID-19 edition, updated Feb 2022. Read the complete edition here.
Nasal high flow use on COVID-19 patients has been observed to:
“[NHF] use is associated with a reduction in the rate of invasive mechanical ventilation and overall mortality in patients with COVID-19 infection.” - Patel et al. 2020.
The number of organizations that have published evidence-based guidelines recommending the use of NHF for COVID-19 patients continues to grow:
You might also be interested in:
Evidence and guidance for delivering Optiflow NHF, proven respiratory support for your patients.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks and full face NIV masks, with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Delivering warm, humidified carbon dioxide in laparoscopic and open surgery
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment